Lymphangiogenic factors such as vascular endothelial growth factor (VEGF)‐C, which binds to VEGF receptor‐3 (VEGFR‐3), increase the ability of lymphatic vessels to invade tumours 6. This evidence concerns the gene FLT4 and neoplasm.